BACKGROUND	American College of Cardiology/American Heart Association/European Society of Cardiology ( ACC/AHA/ESC ) guidelines gave fondaparinux a class I recommendation for use in patients with non-ST elevation acute coronary syndromes ( NSTE-ACS ) undergoing invasive or conservative strategy .\